FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056173053> ?p ?o ?g. }

• W2056173053 endingPage "408" @default.
• W2056173053 startingPage "395" @default.
• W2056173053 abstract "British Journal of HaematologyVolume 60, Issue 3 p. 395-408 THE MOLECULAR BIOLOGY OF CHRONIC MYELOGENOUS LEUKAEMIA Robert Peter Gale, Corresponding Author Robert Peter Gale Department of Medicine (Hematology and Oncology), UCLA School of Medicine, Los Angeles, California 90024, U.S.A.Dr R. P. Gale, Department of Medicine (Hematology and Oncology), UCLA School of Medicine, Los Angeles, California 90024, U.S.A.Search for more papers by this authorEli Cannani, Eli Cannani Department of Chemical Immunology, Weizmann Institute of Science, Rehovot 76100, IsraelSearch for more papers by this author Robert Peter Gale, Corresponding Author Robert Peter Gale Department of Medicine (Hematology and Oncology), UCLA School of Medicine, Los Angeles, California 90024, U.S.A.Dr R. P. Gale, Department of Medicine (Hematology and Oncology), UCLA School of Medicine, Los Angeles, California 90024, U.S.A.Search for more papers by this authorEli Cannani, Eli Cannani Department of Chemical Immunology, Weizmann Institute of Science, Rehovot 76100, IsraelSearch for more papers by this author First published: July 1985 https://doi.org/10.1111/j.1365-2141.1985.tb07436.xCitations: 51AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Abelson, H.T. & Rabstein, L.S. (1970) Lymphosarcoma: virus involved thymic-independent disease in mice. Cancer Research, 30, 2213–2222. Bartram, C.R., de Klein, A, Hagemeijer, A, et al (1983) Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature, 306, 277–280. Bartram, C.R., de Klein, A, Hagemeijer, A., Grosweld, G., Heistercamp, N. & Groffen, J. (1984) Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization. Blood, 63, 223–225. Bartram, C.R., de Klein, A & Grosveld, G. (1985) c-abl and bcr rearrangements in Ph1-negative CML. In: Leukemia: Recent Advances, Future Directions (ed. by R. P. Gale and D. W. Golde). A. R. Liss, New York . Benyajati, C., Spoerel, N., Haymerle, H. & Ashburner, M. (1983) The messenger RNA for alochol dehydrodenase in Drosophila melanogaster differs in its 5′ and in different developmental stages. Cell, 33, 125–133. Bernheim, A., Berger, R., Preud'homme, J.L., Labaume, S., Bussel, A. & Borot-Ciorbaru, R. (1981) Philadelphia chromosome positive blood B lymphocytes in chronic myelogenous leukemia. Leukaemia Research, 5, 331–339. Birnie, G.D., Burns, J.H., Clark, P. & Warnock, A.M. (1984) Lineage-specific and differentiation-stage-specific gene expression in normal and leukaemic human myeloid cells. Journal of Royal Society of Medicine 77, 289–294. Birnie, G.D., Burns, J.H., Wiedemann, L.M., Warnock, A.M. & Tindle, R.W. (1983) A new approach to the classification of human leukaemias: measurement of the relative abundance of a specific RNA sequence by means of molecular hybridization. Lancet, i, 197–200. Bishop, M.J. (1983) Cellular oncogenes and retroviruses. Annual Review of Biochemistry, 52, 301–354. Blick, M., Westin, E, Gutterman, J et al (1984) Oncogene expression in human leukemia. Blood, 64, 1234–1239. Broxmeyer, H.E., Smithyman, A., Eger, R.R., Meyers, P.A. & de Sousa, M (1978) Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production. Journal of Experimental Medicine, 148, 1052–1067. Cannani, E., Gale, R.P, Steiner-Saltz, D, et al (1984) Altered transcription of an oncogene in chronic myeloid leukaemia. Lancet, i, 593–595. Champlin, R.E. & Golde, D.W. (1985) Chronic myelogenous leukemia: recent advances. Blood, 65, 1039–1047. Collins, S.J., Kubonishi, I., Miyoshi, I. & Groudine, M.T. (1984) Altered transcription of the c-abl oncogene in K562 and other chronic myelogenous leukemia cells. Science, 225, 72–74. Collins, S.J. & Groudine, M.T. (1983) Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proceedings of the National Academy of Sciences of the United States of America, 80, 4813–4817. Dalla-Favera, R., Gallo, R.C., Giallongo, A. & Croce, C.M. (1982) Chromosomal localization of the human homolog (c-sis) of the simian sarcoma virus onc-gene. Science, 218, 686–688. Davis, R.L., Konopka, J.B. & Witte, O.N. (1985) Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Molecular Cellular Biology, 5, 204–213. de Klein, A, Geurts van Kessel, A., Grosveld, G., et al (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature, 300, 765–767. Deuel, T.F., Huang, J.S., Huang, S.S., Stroobant, P. & Waterfield, M.D. (1983) Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed genes. Science, 221, 1348–1350. Devare, S.G., Reddy, E.P., Law, J.D., Robbins, K.C. & Aaronson, S.A. (1983) Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28 sis Proceedings of the National Academy of Sciences of the United States of America, 80, 731. Dube, I.D., Kagmark, K., Coulombel, L., Gupta, M., Eaves, C.J. & Eaves, A.C. (1984a) Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated newly diagnosed patients. Blood, 63, 1172–1177. Dube, I.D., Arlin, Z.A., Kalousek, D.K., Eaves, C.J. & Eaves, A.C. (1984b) Non-clonal hemopoietic progenitor cells detected in long-term marrow cultures from a Turner syndrome mosaic with chronic myeloid leukemia. Blood, 64, 1284–1287. Erikson, J., Martinis, J. & Croce, C.M. (1981) Assignment of the genes for human immunoglobulin chains to chromosome 22. Nature, 294, 173. Eva, A., Tronick, S.R., Gol, R.A., Pierce, J.H. & Aaronson, S.A. (1983b) Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype. Proceedings of the National Academy of Sciences of the United Staes of America, 80, 4926–4930. Fialkow, P.J., Martin, P.J., Najfeld, V., Penfold, G.K., Jacobson, R.J. & Hansen, J.A. (1981) Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood, 58, 158–163. Francis, G.E., Michalevicz, R. & Wickrensinghe, R.G. (1983) Chronic myeloid leukemia and the Philadelphia translocation: Do the ci-sis oncogene and the platelet derived growth factor provide the link? Leukemia Research, 7, 817–820. Gale, R.P. & Cannani, E. (1984) A novel 8 Kb abl RNA transcript in chronic myelogenous leukemia. Proceedings of the National Academy of Sciences of the United States of America, 81, 5648–5652. Goldman, J.M. & Lu Dao-Pei (1982) New approaches in chronic granulocytic leukemia–origin, prognosis, and treatment. Seminars in Haematology, 19, 241–256. Goyns, M.H., Young, B.D, Geurts, A, et al (1984) Regional mapping of the human immunoglobulin lambda light chain to the Philadelphia chromosome in chronic myeloid leukemia. Leukemia Research, 8, 547–553. Greenberger, J.S., Davisson, P.B., Gans, P.J. & Moloney, W.C. (1979) In vitro induction of continuous acute promyelocytic leukemia cell lines by Friend or Abelson murine leukemia virus. Blood, 53, 987–1001. Groffen, J., Heisterkamp, N, Stephenson, J.R et al (1983) c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. Journal of Experimental Medicine, 158, 9–15. Groffen, J., Stephenson, J.R., Heisterkamp, N., de Klein, A, Bartram, C.R. & Grosveld, G. (1984) Philadelphia chromosomal breakpoints are clusted within a limited region, bcr, on chromosome 22. Cell, 36, 93–99. Grunwald, D.J., Dale, B., Dudley, J., Lamph, W., Sugden, S., Ozanne, B. & Risser, R. (1982) Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells. Journal of Virology, 43, 92–103. Hagemeijer, A., Bortrom, C.R., Smit, E.M.E., van Agthoven, A.J & Bootsma, D. (1984) Is the chromosomal region gq34 always involved in variants of the Ph1 translocation? Cancer Genetics and Cytogenetics, 13, 1–16. Heisterkamp, N.Y., Groffen, J, Stephenson, J.R, et al (1982) Chromosomal localization of human cellular homologues of two viral oncogenes. Nature, 299, 747–750. Heisterkamp, N., Stephenson, J.R, Groffen, J et al (1983) Localization of the c-abl oncogene adjacent to a translocation breakpoint in chronic myelocytic leukaemia. Nature, 306, 239–242. Heisterkamp, N., Groffin, J., de Klein, A & Grosveld, G. (1985) Distribution of Ph1 break-points in the bcr region on chromosome 22. (Abstract). Journal of Cell Biochemistry, Suppl. 9A, 84. Kirsch, I.R., Morton, C.C., Nakahara, K. & Leder, P. (1982) Human immunoglobulin heavy chain genes map to a region of translocations in malignant B lymphocytes. Science, 216, 301. Kloetzer, W., Kurzrock, R, Smith, L, et al (1985) The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology, 140, 230–238. Koeffler, P. & Golde, D.W. (1981) Chronic myelogenous leukemia–new concepts. New England Journal of Medicine, 304, 1201–1209. Konopka, J.B., Watanabe, S.M & Witte, O.N. (1984) An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell, 37, 1035–1042. Konopka, J.B., Watanabe, S.M., Singer, J.W., Collins, S.J. & Witle, O.N. (1985) Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proceedings of the National Academy of Sciences of the United States of America, 82, 1810–1814. Lane, M.-A., Neary, D. & Cooper, G.M. (1982) Activation of cellular transforming gene in tumours induced by Abelson murine leukaemia virus. Nature, 300, 637–639. Lisker, R., Casas, L., Mutchinick, O., Perez-Chavez, F. & Labardini, J. (1980) Late-appearing Philadelphia chromosome in two patients with chronic myelogenous leukemia. Blood, 56, 812–814. Marmont, A., Frassoni, F, Bacigalupo, A, et al (1984) Recurrence of Ph1 positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. New England Journal of Medicine, 310, 903–906. Mars, W.M., Florine, D.L., Talpaz, M. & Saunders, G.F. (1985) Preferentially expressed genes in chronic myelogenous leukemia. Blood, 65, 1218–1225. Martin, P.J., Najfeld, V., Hansen, J.A., Penfold, G.K., Jacobson, R.J. & Fialkow, P.J. (1980) Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature, 287, 49–50. McBride, O.W., Hieter, P.A., Hollis, G.F., Swan, D., Otey, M.C., & Leder, P. (1982) Chromosomal localization of human kappa and lambda immunoglobulin light chain constant region genes. Journal of Experimental Medicine, 155, 1480. McCarthy, D.M., Rassool, F.V., Goldman, J.M., Graham, S.V. & Birnie, G.D. (1984) Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia. Lancet, i, 1362–1365. McClain, K.L. (1984) Expression of oncogenes in human leukemias. Cancer Research, 44, 5382–5389. Michalevicz, R., Francis, G.E., Price, G.M. & Hoffbrand, A.V. (1985) The role of platelet-derived growth factor on human pluripotent progenitor (CFU-GEMM) growth in vitro. Leukemia Research, 9, 399–405. Mitelman, F. & Levan, G. (1978) Clustering of aberrations to specific chromosomes in human neoplasms. Hereditas, 89, 207–232. Nienhuis, A.W., Anagnou, N.P. & Ley, T.J. (1984) Advances in thalassemia research. Blood, 63, 738–758. Nowell, P.C. & Hungerford, D.A. (1960) A minute chromosome in human chronic granulocytic leukemia. Journal of the National Cancer Institute, 25, 85–109. Olofsson, T. & Olsson, I. (1980) Suppression of normal granulopoiesis in vitro by a leukemia-associated inhibitor (LAI) of acute and chronic leukemia. Blood, 55, 975–982. Ozanne, B., Wheeler, T., Zach, J., Smith, G. & Dale, B. (1982) Transforming gene of a human leukemia cell is unrelated to the expressed tumor virus related gene of the cell. Nature, 299, 744–747. Pierce, J., Eva, A. & Aaronson, S.A. (1984) Hematopoietic cell targets for transformation by retroviral oncogenes. New Trends in Experimental Hematology (ed. by C. Peschle and C. Rizzoli), pp. 1–18. Serono Symposia. Rome . Ponticelli, A.S., Whitlock, C.A., Rosenberg, N. & Witte, O.N. (1982) In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homolog. Cell, 29, 953–960. Potter, M., Sklar, M.D. & Rowe, W.P. (1973) Rapid viral induction of plasmacytomas in pristane-primed Balb/c mice. Science, 182, 592–594. Prakash, O. & Yunis, J.J. (1984) High resolution chromosomes of the t(9;22) positive leukemias. Cancer Genetics and Cytogenetics, 11, 361–367. Prywes, R., Foulkes, J.G., Rosenberg, N. & Baltimore, D. (1983) Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell, 34, 569–579. Raschke, W.C., Baird, S., Ralph, P. & Nakoinz, I. (1978) Functional macrophage cell lines transformed by Abelson leukemia virus. Cell, 15, 261–267. Rosenfeld, M., Keating, A., Bowen-Pope, D.F., Singer, J.W. & Ross, R. (1985) Responsiveness of the in vitro hematopoietic microenvironment to platelet derived growth factor. Leukemia Research, 9, 427–434. Rowley, J.D. & Testa, J.R. (1982) Chromosomal abnormalities in malignant hematologic diseases. Advances in Cancer Research, 36, 103–148. Rowley, J.D. (1973) A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining. Nature, 243, 290–293. Rowley, J.D. (1982) Identification of the constant chromosome regions involved in human hematologic malignancy disease. Science, 216, 749–751. Sandberg, A.A. (1980) Chromosomes and causation of human cancer and leukemia. XL. The Ph1 and other translocations in CML. Cancer, 46, 2221–2226. Schibler, U., Hagenbuchle, O., Wellbauer, P.K. & Pittet, A.C. (1983) Two promoters of different strengths control the transcription of the mouse alpha-amylase gene amy-la in the parathyroid gland and the liver. Cell, 33, 501–508. Selden, J.R., Emanuel, B.S, Wang, E, et al (1983) Amplified Cλ and c-abl genes are on the same marker chromosome in K562 leukemia cells. Proceedings of the National Academy of Sciences of the United States of America, 80, 7289–7292. Shtivelman, E., Lifshitz, B., Gale, R.P. & Cannani, E. (1985) A fused transcript of the abl and bcr genes in chronic myelogenous leukaemia. Nature (in press). Stiles, C.D. (1983) The molecular biology of platelet-derived growth factor. Cell, 33, 653–635. Swan, D.C., McBride, O.W., Robbins, K.C., Keithley, D.A., Reddy, E.P. & Aaronson, S.A. (1982) Chromosomal mapping of the simian sarcoma virus onc gene analogue in human cells. Proceedings of the National Academy of Sciences of the United States of America, 79, 4691–4695. Teyssier, J.R., Bartram, C.R., Deville, J., Potron, G. & Pigeon, F. (1985) c-abl oncogene and chromosome 22 ‘bcr’ juxtaposition in chronic myelogenous leukemia. New England Journal of Medicine, 312, 1393–1394. Westin, E.H., Wong-Staal, F, Gelmann, E.P, et al (1982) Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America, 79, 2490–2499. Whitlock, C.A. & Witte, O.N. (1981) Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential. Journal of Virology, 40, 577–584. Witte, O.N., Coff, S., Rosenbert, N. & Baltimore, D. (1980) A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity. Proceedings of the National Academy of Sciences of the United States of America, 77, 4993–4997. Yunis, J.J. (1983) The chromosomal basis of human neoplasm. Science, 221, 227–236. Citing Literature Volume60, Issue3July 1985Pages 395-408 ReferencesRelatedInformation" @default.
• W2056173053 created "2016-06-24" @default.
• W2056173053 creator A5003712198 @default.
• W2056173053 creator A5056928057 @default.
• W2056173053 date "1985-07-01" @default.
• W2056173053 modified "2023-10-16" @default.
• W2056173053 title "THE MOLECULAR BIOLOGY OF CHRONIC MYELOGENOUS LEUKAEMIA" @default.
• W2056173053 cites W1598914661 @default.
• W2056173053 cites W1694353122 @default.
• W2056173053 cites W1760723619 @default.
• W2056173053 cites W1918026655 @default.
• W2056173053 cites W1966166167 @default.
• W2056173053 cites W1969578383 @default.
• W2056173053 cites W1971331718 @default.
• W2056173053 cites W1974852313 @default.
• W2056173053 cites W1975812434 @default.
• W2056173053 cites W1983171249 @default.
• W2056173053 cites W1983650558 @default.
• W2056173053 cites W1990313254 @default.
• W2056173053 cites W1990392921 @default.
• W2056173053 cites W1990406235 @default.
• W2056173053 cites W1992672820 @default.
• W2056173053 cites W1998593414 @default.
• W2056173053 cites W2000991239 @default.
• W2056173053 cites W2005169778 @default.
• W2056173053 cites W2005413198 @default.
• W2056173053 cites W2007457898 @default.
• W2056173053 cites W2008353412 @default.
• W2056173053 cites W2011346454 @default.
• W2056173053 cites W2012399090 @default.
• W2056173053 cites W2012432612 @default.
• W2056173053 cites W2020092689 @default.
• W2056173053 cites W2023339831 @default.
• W2056173053 cites W2023942015 @default.
• W2056173053 cites W2028957701 @default.
• W2056173053 cites W2030227371 @default.
• W2056173053 cites W2032512678 @default.
• W2056173053 cites W2034280067 @default.
• W2056173053 cites W2034892057 @default.
• W2056173053 cites W2038077658 @default.
• W2056173053 cites W2043423684 @default.
• W2056173053 cites W2044167739 @default.
• W2056173053 cites W2056041200 @default.
• W2056173053 cites W2059970016 @default.
• W2056173053 cites W2060833726 @default.
• W2056173053 cites W2061177902 @default.
• W2056173053 cites W2063334249 @default.
• W2056173053 cites W2068348059 @default.
• W2056173053 cites W2074473537 @default.
• W2056173053 cites W2077326676 @default.
• W2056173053 cites W2086080576 @default.
• W2056173053 cites W2086178365 @default.
• W2056173053 cites W2087345258 @default.
• W2056173053 cites W2089639142 @default.
• W2056173053 cites W2092299362 @default.
• W2056173053 cites W2101391649 @default.
• W2056173053 cites W2115524556 @default.
• W2056173053 cites W2116223278 @default.
• W2056173053 cites W2119175977 @default.
• W2056173053 cites W2125861481 @default.
• W2056173053 cites W2146319645 @default.
• W2056173053 cites W2180795626 @default.
• W2056173053 cites W2195794458 @default.
• W2056173053 cites W2267139310 @default.
• W2056173053 cites W2294265686 @default.
• W2056173053 cites W2322475438 @default.
• W2056173053 cites W2336827992 @default.
• W2056173053 cites W2404887513 @default.
• W2056173053 cites W2414381212 @default.
• W2056173053 cites W2417307145 @default.
• W2056173053 cites W2469832691 @default.
• W2056173053 cites W283495653 @default.
• W2056173053 cites W314055174 @default.
• W2056173053 cites W4233157183 @default.
• W2056173053 cites W4242596830 @default.
• W2056173053 cites W95101793 @default.
• W2056173053 doi "https://doi.org/10.1111/j.1365-2141.1985.tb07436.x" @default.
• W2056173053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3893521" @default.
• W2056173053 hasPublicationYear "1985" @default.
• W2056173053 type Work @default.
• W2056173053 sameAs 2056173053 @default.
• W2056173053 citedByCount "55" @default.
• W2056173053 crossrefType "journal-article" @default.
• W2056173053 hasAuthorship W2056173053A5003712198 @default.
• W2056173053 hasAuthorship W2056173053A5056928057 @default.
• W2056173053 hasConcept C203014093 @default.
• W2056173053 hasConcept C2776960273 @default.
• W2056173053 hasConcept C2778461978 @default.
• W2056173053 hasConcept C502942594 @default.
• W2056173053 hasConcept C70721500 @default.
• W2056173053 hasConcept C71924100 @default.
• W2056173053 hasConcept C86803240 @default.
• W2056173053 hasConceptScore W2056173053C203014093 @default.
• W2056173053 hasConceptScore W2056173053C2776960273 @default.
• W2056173053 hasConceptScore W2056173053C2778461978 @default.
• W2056173053 hasConceptScore W2056173053C502942594 @default.
• W2056173053 hasConceptScore W2056173053C70721500 @default.
• W2056173053 hasConceptScore W2056173053C71924100 @default.

• next